A study reveals that shape-shifting immune cells, intermediate ILC2s, may contribute to severe asthma and resistance to ...
Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- A set of chameleon-like immune cells could be contributing to severe asthma in ...
If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...
Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for severe asthma, challenges remain in managing T-helper cell type 2 (T2 ...
The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...
Juan Celedón and his research team have altered the possibilities of future asthma treatment by uncovering a new way to ...